NSE: PFIZER | BSE: 500680

Expensive Performer

Download real time

4268.40 -5.70 (-0.13%)

33.84% Fall from 52W High

14,632 NSE+BSE Volume

NSE 29 Apr, 2025 3:31 PM (IST)

19,526.9

Market Cap

High in industry

0.4

Beta 1Year

Very Low volatility

Pfizer Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Pfizer Ltd. from all sources in a single place.

Load latest

04 Nov 2024

4268.40

-0.13%

Pfizer Q2 Results Review - Subuded Growth, NCE Pipeline Commercialisation Is Awaited: Systematix

NDTV Profit

The brokerage upgrades its rating from Hold to Buy with a price target of Rs 6,375.

Pfizer Ltd. is trading below its 100 day SMA of 4517.4

28 Oct 2024, 08:11PM

4268.40

-0.13%

Pfizer Q2 Results: Profit Rises 6.3%, Misses Estimates

NDTV Profit

Pfizer's margin expanded 41 basis points to 32.15% in the September quarter.

Pfizer Ltd. is trading below its 100 day SMA of 4517.4

28 Oct 2024, 08:09PM

4268.40

-0.13%

Company Update

PFIZER LTD. - 500680 - Statement Of Related Party Transactions For The Half Year Ended September …

BSE India

Statement of Related Party Transactions for the half year ended September 30, 2024

28 Oct 2024, 06:05PM

4268.40

-0.13%

Board Meeting

PFIZER LTD. - 500680 - Board Meeting Outcome for Outcome Of The Board Meeting-Unaudited Financial Results …

BSE India

Outcome of the Board Meeting-Unaudited Financial Results for the quarter and half year ended September 30, 2024

21 Oct 2024

4268.40

-0.13%

Board Meeting

PFIZER LTD. - 500680 - Board Meeting Intimation for To Consider And Take On Record The …

BSE India

PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and half year ended September 30, 2024.

16 Oct 2024

4268.40

-0.13%

Corp. Note

PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate …

BSE India

Intimation regarding loss of share certificates and issue of Letter of Confirmation.

11 Oct 2024

4268.40

-0.13%

USFDA approves Pfizer's Hympavzi for rare bleeding disorder hemophilia

Business Standard

The drug, Hympavzi, is given under the skin through an auto-injector pen to prevent or reduce bleeding episodes in hemophilia A or B patients aged 12 years and older

Pfizer Ltd. is trading below its 100 day SMA of 4517.4

10 Oct 2024

4268.40

-0.13%

Ex Pfizer CEO, CFO not to involve in Starboard's campaign on drugmaker

Business Standard

Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of its COVID products shrink

Pfizer Ltd. is trading below its 100 day SMA of 4517.4

08 Oct 2024

4268.40

-0.13%

Corp. Note

PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate …

BSE India

Intimation regarding loss of share certificates and issue of Letter of Confirmation.

08 Oct 2024

4268.40

-0.13%

Company Update

PFIZER LTD. - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2024.

Is Pfizer Ltd. worth buying?

202 Votes:

Buy 75.25%

Sell 14.85%

Hold 9.9%